tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 109 are a HOLD (35.86%), 193 are a BUY (63.49%), 2 are a SELL (0.66%).
Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 48.37% that have a potential upside of 48.24% achieved within 188 days.
Luca Issi’s has documented 581 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on QURE, Uniqure NV at 09-Mar-2026.
Analyst best performing recommendations are on FDMT (4D MOLECULAR THERAPEUTICS ).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 1/29/2024. The price target of $25 was fulfilled within 7 days with a profit of $6.98 (38.73%) receiving and performance score of 55.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Nov-2018
$8
$5.74 (253.98%)
18 days ago
(13-Mar-2026)
2/10 (20%)
$5.6 (233.33%)
3
Buy Since 04-Nov-2019
18 days ago
(13-Mar-2026)
1/2 (50%)
$28.66 (452.05%)
192
$5
$2.74 (121.24%)
2 months 22 days ago
(09-Jan-2026)
1/9 (11.11%)
$3.29 (192.40%)
148
Sell Since 10-Oct-2025
5 months 21 days ago
(10-Oct-2025)
0/3 (0%)
$2.86 (55.64%)
Buy Since 23-Oct-2020
$9
$6.74 (298.23%)
8 months 24 days ago
(07-Jul-2025)
0/5 (0%)
$7.84 (675.86%)
Which stock is Luca Issi is most bullish on?
Which stock is Luca Issi is most reserved on?
What Year was the first public recommendation made by Luca Issi?
